Qing Xie

11.8k total citations
232 papers, 5.0k citations indexed

About

Qing Xie is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Qing Xie has authored 232 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Epidemiology, 125 papers in Hepatology and 39 papers in Molecular Biology. Recurrent topics in Qing Xie's work include Liver Disease Diagnosis and Treatment (106 papers), Hepatitis B Virus Studies (101 papers) and Hepatitis C virus research (92 papers). Qing Xie is often cited by papers focused on Liver Disease Diagnosis and Treatment (106 papers), Hepatitis B Virus Studies (101 papers) and Hepatitis C virus research (92 papers). Qing Xie collaborates with scholars based in China, United States and Australia. Qing Xie's co-authors include Hui Wang, Vladimir I. Khaoustov, Boris Yoffe, Shisan Bao, Xianqun Fan, Xiaogang Xiang, Jidong Jia, Wei Cai, Xiaoping Bi and Bhuvaneswari Krishnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Qing Xie

218 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Xie China 37 2.5k 2.1k 1.2k 433 411 232 5.0k
Moon Young Kim South Korea 44 2.8k 1.2× 2.7k 1.3× 794 0.7× 1.3k 3.0× 170 0.4× 202 5.7k
Mariko Kobayashi Japan 45 5.9k 2.4× 5.6k 2.6× 910 0.8× 740 1.7× 403 1.0× 356 8.3k
Juan Armendáriz‐Borunda Mexico 36 1.2k 0.5× 932 0.4× 1.2k 1.0× 486 1.1× 110 0.3× 177 4.1k
Hongcui Cao China 38 1.2k 0.5× 1.1k 0.5× 1.6k 1.4× 1.1k 2.6× 434 1.1× 220 5.6k
Yilei Mao China 36 838 0.3× 937 0.4× 1.1k 1.0× 989 2.3× 564 1.4× 210 4.4k
Clark A. Bonham United States 27 631 0.3× 861 0.4× 716 0.6× 1.3k 3.0× 419 1.0× 78 4.7k
Marcos Rojkind United States 49 2.8k 1.1× 3.3k 1.6× 2.5k 2.1× 1.5k 3.5× 255 0.6× 142 8.6k
Jing Hua China 46 1.1k 0.5× 371 0.2× 2.7k 2.3× 781 1.8× 360 0.9× 215 7.3k
Peter R. Mertens Germany 53 886 0.4× 629 0.3× 2.9k 2.5× 1.6k 3.7× 214 0.5× 249 8.3k
Yanfang Jiang China 39 802 0.3× 521 0.2× 1.3k 1.1× 566 1.3× 144 0.4× 244 5.4k

Countries citing papers authored by Qing Xie

Since Specialization
Citations

This map shows the geographic impact of Qing Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Xie more than expected).

Fields of papers citing papers by Qing Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Xie. The network helps show where Qing Xie may publish in the future.

Co-authorship network of co-authors of Qing Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Xie. A scholar is included among the top collaborators of Qing Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Xie. Qing Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Seng Gee, Marc Bourlière, Nathalie Ganne‐Carrié, et al.. (2025). HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER). Gut. gutjnl–2025. 1 indexed citations
2.
Chen, Yaoxing, Gan Jiang, Yan Huang, et al.. (2025). Lipoprotein‐Based Nanocatalyst Enables Targeted Treatment of APAP‐Induced Liver Injury via Enhanced Macropinocytosis. Advanced Healthcare Materials. 14(25). e2500507–e2500507. 1 indexed citations
3.
Cao, Zhujun, Yuhan Liu, Haiguang Xin, et al.. (2024). Blood markers for type-1, -2, and -3 inflammation are associated with severity of acutely decompensated cirrhosis. Journal of Hepatology. 82(5). 836–850. 3 indexed citations
4.
Xie, Qing, et al.. (2024). Prognosis algorithms for acute decompensation of cirrhosis and ACLF. Liver International. 45(3). e15927–e15927. 2 indexed citations
5.
Han, Dingpei, Yuqin Cao, Chengqiang Li, et al.. (2024). Ultra-short-period perioperative pulmonary rehabilitation on short-term outcomes after surgery in smoking patients with lung cancer: a randomized clinical trial. International Journal of Surgery. 111(1). 581–588. 1 indexed citations
6.
Huang, Yan, et al.. (2023). Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone. Journal of Viral Hepatitis. 30(10). 803–809. 8 indexed citations
7.
Huang, Yan, et al.. (2022). qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT Levels. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–7. 2 indexed citations
8.
Sun, Jian, Bin Zhou, Qing Xie, et al.. (2020). A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients. Alimentary Pharmacology & Therapeutics. 51(4). 469–478. 14 indexed citations
9.
Sonneveld, Milan J., Willem Pieter Brouwer, Bettina E. Hansen, et al.. (2020). Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis. Alimentary Pharmacology & Therapeutics. 52(8). 1399–1406. 20 indexed citations
10.
Chen, Mingjiao, Yuanhao Zhang, Qing Xie, et al.. (2019). Long-Term Bone Regeneration Enabled by a Polyhedral Oligomeric Silsesquioxane (POSS)-Enhanced Biodegradable Hydrogel. ACS Biomaterials Science & Engineering. 5(9). 4612–4623. 40 indexed citations
11.
Chan, Henry Lik‐Yuen, Diethelm Messinger, George Papatheodoridis, et al.. (2018). A baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 48(5). 547–555. 22 indexed citations
12.
Campenhout, Margo J. H. van, Willem Pieter Brouwer, Qing Xie, et al.. (2018). Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Journal of Viral Hepatitis. 26(1). 109–117. 14 indexed citations
13.
Shen, Sheng, Xieer Liang, Kamal Hamed, et al.. (2017). Effect of hepatitis B virus subgenotype on antiviral response in nucleoside‐treated hepatitis B envelope antigen‐positive patients. Hepatology Research. 48(2). 134–143. 13 indexed citations
14.
Rao, Huiying, Lai Wei, Hong Li, et al.. (2015). Prevalence of abnormal glycometabolism in treatment‐naive patients with hepatitis C virus infection in a C hinese H an population. Journal of Gastroenterology and Hepatology. 30(6). 1049–1056. 5 indexed citations
15.
16.
Shang, Jia, Xiaoyuan Xu, Xinyue Chen, et al.. (2015). Efficacy and related factors of pegylated interferon α-2a plus ribavirin therapy for chronic hepatitis C in non-responders. 8(3). 232–237. 1 indexed citations
17.
Xie, Qing. (2011). microRNAs:Novel regulators during the immune response. 1 indexed citations
18.
Lin, Lingnan, Vincent Wai‐Sun Wong, Huijuan Zhou, et al.. (2010). Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg‐negative patients. Journal of Medical Virology. 82(9). 1494–1500. 53 indexed citations
19.
Xie, Qing. (2009). Clinical value of typical features of thyroid nodules on ultrasonography.
20.
Xie, Qing. (2001). Study of uterine blood flow hemodynamics by transvaginal color Doppler ultrasonography in postmenopausal women. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moon Young Kim Breakdown of academic impact, for papers by Mariko Kobayashi Breakdown of academic impact, for papers by Juan Armendáriz‐Borunda Breakdown of academic impact, for papers by Hongcui Cao Breakdown of academic impact, for papers by Yilei Mao Breakdown of academic impact, for papers by Clark A. Bonham Breakdown of academic impact, for papers by Marcos Rojkind Breakdown of academic impact, for papers by Jing Hua Breakdown of academic impact, for papers by Peter R. Mertens Breakdown of academic impact, for papers by Yanfang Jiang
Rankless by CCL
2026